Tarek Sahmoud - 12 Aug 2022 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role
Chief Medical Officer
Signature
/s/ Alex Levit, Attorney-in-Fact
Issuer symbol
CNTX
Transactions as of
12 Aug 2022
Net transactions value
$0
Form type
4
Filing time
12 Aug 2022, 16:31:15 UTC
Previous filing
19 Oct 2021
Next filing
17 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNTX Stock Option (right to buy) Award $0 +25,000 $0.000000 25,000 12 Aug 2022 Common Stock 25,000 $1.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable over a two-year period. Fifty percent (50%) of the option vests and becomes exercisable on June 17, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining one year of the two-year period, subject to continued service with the Issuer.